CTCs exhibit the overexpression of CXCR4, while chemokine stromal cell-derived factor-1 (SDF-1, also known as CXCL12), which recruits and retains CXCR4+ cells, shows significant upregulation at the primary tumor site. This evidence concerns the gene CXCL12 and neoplasm.